Epitel

Epitel, Inc. is a digital health company based in Salt Lake City, Utah, specializing in innovative wearable EEG monitoring technology for brain health. Founded in 2008, Epitel developed the REMI™ Remote EEG Monitoring System, an FDA-cleared (2021) wireless, wearable sensor platform designed for seizure detection and electrographic monitoring in both hospital and ambulatory settings. The system features single-channel, high-fidelity EEG recordings with rapid setup (minutes), wireless operation enabling patient mobility, and integration with standard EEG review platforms like Persyst™ Mobile for remote clinician review. REMI Vigilenz™ AI for Event Detection augments clinical review by automatically identifying potential electrographic seizure activity with confidence scoring. The platform is clinically validated, reimbursable under existing codes, and suitable for adult and pediatric patients (1+ years for monitoring; 6+ years for AI analysis). Epitel's technology addresses critical care, emergency department, and outpatient epilepsy monitoring needs. The company has secured over $20 million in funding and brings extensive expertise in medical device development, neural engineering, and regulatory affairs.